1. Home
  2. CPAC vs AVXL Comparison

CPAC vs AVXL Comparison

Compare CPAC & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • AVXL
  • Stock Information
  • Founded
  • CPAC 1949
  • AVXL 2004
  • Country
  • CPAC Peru
  • AVXL United States
  • Employees
  • CPAC N/A
  • AVXL N/A
  • Industry
  • CPAC Building Materials
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CPAC Industrials
  • AVXL Health Care
  • Exchange
  • CPAC Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • CPAC 494.0M
  • AVXL 484.2M
  • IPO Year
  • CPAC 2012
  • AVXL N/A
  • Fundamental
  • Price
  • CPAC $6.34
  • AVXL $7.45
  • Analyst Decision
  • CPAC Sell
  • AVXL Strong Buy
  • Analyst Count
  • CPAC 1
  • AVXL 2
  • Target Price
  • CPAC $6.00
  • AVXL $43.00
  • AVG Volume (30 Days)
  • CPAC 14.1K
  • AVXL 1.6M
  • Earning Date
  • CPAC 10-29-2024
  • AVXL 11-25-2024
  • Dividend Yield
  • CPAC 8.54%
  • AVXL N/A
  • EPS Growth
  • CPAC 7.38
  • AVXL N/A
  • EPS
  • CPAC 0.12
  • AVXL N/A
  • Revenue
  • CPAC $527,798,215.00
  • AVXL N/A
  • Revenue This Year
  • CPAC N/A
  • AVXL N/A
  • Revenue Next Year
  • CPAC N/A
  • AVXL N/A
  • P/E Ratio
  • CPAC $10.96
  • AVXL N/A
  • Revenue Growth
  • CPAC N/A
  • AVXL N/A
  • 52 Week Low
  • CPAC $4.65
  • AVXL $3.25
  • 52 Week High
  • CPAC $6.65
  • AVXL $10.45
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 59.62
  • AVXL 54.68
  • Support Level
  • CPAC $6.23
  • AVXL $7.55
  • Resistance Level
  • CPAC $6.48
  • AVXL $10.45
  • Average True Range (ATR)
  • CPAC 0.25
  • AVXL 0.84
  • MACD
  • CPAC -0.00
  • AVXL 0.08
  • Stochastic Oscillator
  • CPAC 57.53
  • AVXL 37.77

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: